NTRA

Nasdaq

Natera, Inc.

Latest disclosureOctober 2, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 273 sales

Price by TradingView

Insider transactions 310

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $63.19M by 4 insiders.

Showing the first 6 of 20 trades on this page.

Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value: $526.14K
Reported price: $413.31 / share

Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value: $82.32K
Reported price: $411.62 / share

Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value: $394.1K
Reported price: $413.1066 / share

Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value: $766.22K
Reported price: $415.0691 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $154.04K
Reported price: $385.1025 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $841.1K
Reported price: $386.7144 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $1.06M
Reported price: $387.6545 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $502.6K
Reported price: $388.7071 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $904.07K
Reported price: $389.685 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $42.95K
Reported price: $390.42 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $150.26K
Reported price: $385.2906 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $889.27K
Reported price: $386.6396 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $1.1M
Reported price: $387.7351 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $521.33K
Reported price: $388.7637 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $754.09K
Reported price: $389.7108 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $85.92K
Reported price: $390.525 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $2.1M
Reported price: $350.0718 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $69.61K
Reported price: $348.025 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $34.9K
Reported price: $349.045 / share

Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value: $495.36K
Reported price: $353.83 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
CEO AND PRESIDENT	Common StockSale10b5-1	1,273$413.31 / share	$526.14K	Oct 1Filed Oct 2 · 1d later	SEC filing
PRESIDENT, CLINICALDIAGNOSTICS	Common StockSale10b5-13 trades	3,000avg $414.22 / share	$1.24M	Oct 1Filed Oct 2 · 1d later	3 filings 200 @ $411.62 · $82.32KSEC filing 954 @ $413.11 · $394.1KSEC filing 1,846 @ $415.07 · $766.22KSEC filing
Director	Common StockSale10b5-112 trades	18,064avg $388.01 / share	$7.01M	Sep 23Filed Sep 25 · 2d later	12 filings 400 @ $385.10 · $154.04KSEC filing 2,175 @ $386.71 · $841.1KSEC filing 2,734 @ $387.65 · $1.06MSEC filing 1,293 @ $388.71 · $502.6KSEC filing 2,320 @ $389.69 · $904.07KSEC filing 110 @ $390.42 · $42.95KSEC filing 390 @ $385.29 · $150.26KSEC filing 2,300 @ $386.64 · $889.27KSEC filing 2,846 @ $387.74 · $1.1MSEC filing 1,341 @ $388.76 · $521.33KSEC filing 1,935 @ $389.71 · $754.09KSEC filing 220 @ $390.53 · $85.92KSEC filing
Director	Common StockSale10b5-1	6,000$350.07 / share	$2.1M	Sep 15Filed Sep 17 · 2d later	SEC filing
Director	Common StockSale10b5-13 trades	1,700avg $352.87 / share	$599.87K	Sep 16Filed Sep 17 · 1d later	3 filings 200 @ $348.03 · $69.61KSEC filing 100 @ $349.05 · $34.9KSEC filing 1,400 @ $353.83 · $495.36KSEC filing

Showing the latest 20 of 273 trades. Show all 273 trades

Congress transactions 1

All Congress filings

Purchase disclosed

Natera, Inc. - Common Stock (NTRA) · Stock

The filing reports a purchase for a joint account.

Josh GottheimerReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 22, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001604821
Latest public acceptance: Oct 3, 2026, 01:35 AM UTC
Score calculated: Oct 8, 2026, 12:08 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

CEO AND PRESIDENT

Common StockSale10b5-1

1,273$413.31 / share

$526.14K

Oct 1Filed Oct 2 · 1d later

SEC filing

PRESIDENT, CLINICALDIAGNOSTICS

Common StockSale10b5-13 trades

3,000avg $414.22 / share

$1.24M

Oct 1Filed Oct 2 · 1d later

3 filings

200 @ $411.62 · $82.32KSEC filing
954 @ $413.11 · $394.1KSEC filing
1,846 @ $415.07 · $766.22KSEC filing

Director

Common StockSale10b5-112 trades

18,064avg $388.01 / share

$7.01M

Sep 23Filed Sep 25 · 2d later

12 filings

400 @ $385.10 · $154.04KSEC filing
2,175 @ $386.71 · $841.1KSEC filing
2,734 @ $387.65 · $1.06MSEC filing
1,293 @ $388.71 · $502.6KSEC filing
2,320 @ $389.69 · $904.07KSEC filing
110 @ $390.42 · $42.95KSEC filing
390 @ $385.29 · $150.26KSEC filing
2,300 @ $386.64 · $889.27KSEC filing
2,846 @ $387.74 · $1.1MSEC filing
1,341 @ $388.76 · $521.33KSEC filing
1,935 @ $389.71 · $754.09KSEC filing
220 @ $390.53 · $85.92KSEC filing

Director

Common StockSale10b5-1

6,000$350.07 / share

$2.1M

Sep 15Filed Sep 17 · 2d later

SEC filing

Director

Common StockSale10b5-13 trades

1,700avg $352.87 / share

$599.87K

Sep 16Filed Sep 17 · 1d later

3 filings

200 @ $348.03 · $69.61KSEC filing
100 @ $349.05 · $34.9KSEC filing
1,400 @ $353.83 · $495.36KSEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001604821
Latest public acceptance: Oct 3, 2026, 01:35 AM UTC
Score calculated: Oct 8, 2026, 12:08 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.